Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy?
These stocks offer high yields, are big names in their respective sectors, and have strong fundamentals.
Overview
Picking a good dividend stock for your portfolio can be challenging, especially when there are many attractive high-yielding options to choose from. And there's much more to consider than just the yield itself.
Below, I'll compare a couple of top dividend stocks: Pfizer (NYSE: PFE) and Verizon Communications (NYSE: VZ). While they're in different sectors, they both may be alluring options for dividend investors because they are blue chip stocks that have been known for generating plenty of dividend income over the years. Pfizer yields around 7.1% while Verizon's payout is closer to 6.7%. They also trade at less than nine times their expected future earnings (based on analyst expectations), making them attractive value buys.
Details
But which one is the better buy? Let's take a look at which one is superior when evaluating multiple criteria.
Source
Originally published at www.fool.com.